Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Atuliflapon Given Orally Once Daily for Twelve Weeks in Adults With Moderate to Severe Uncontrolled Asthma
INTERVENTIONAL
Inicio: 27 de ene de 2022
ID: NCT05251259
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
INTERVENTIONAL
Inicio: 30 de oct de 2019
ID: NCT04133909
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
INTERVENTIONAL
Inicio: 20 de sept de 2016
ID: NCT02918019
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist.
INTERVENTIONAL
Inicio: 13 de jun de 2014
ID: NCT02161757
Completado
Fase 4
ClinicalTrials.gov
A Multi-centre, Open Label, Single Arm, 32-week Treatment Study in Subjects With Severe Eosinophilic Asthma Not Optimally Controlled With Current Omalizumab Treatment Who Are Switched From Omalizumab to Mepolizumab 100mg Subcutaneous (Study Number 204471- the OSMO Study)
INTERVENTIONAL
Inicio: 17 de mar de 2016
ID: NCT02654145
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Phase IIa Study in Asthma Patients Comparing the Efficacy and Safety of Once Daily Inhaled Interferon Beta-1a to Placebo, Administered for 14 Days After the Onset of Symptoms of an Upper Respiratory Tract Infection for the Prevention of Severe Exacerbations
INTERVENTIONAL
Inicio: 21 de jul de 2015
ID: NCT02491684
Completado
ClinicalTrials.gov
Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma
OBSERVATIONAL
Inicio: 8 de oct de 2020
ID: NCT04609774
Completado
ClinicalTrials.gov
Non-invasive Assessment of Lung Recruitment in Morbid Obese Patients Undergoing Bariatric Surgery
INTERVENTIONAL
Inicio: 11 de sept de 2016
ID: NCT03694665
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind Study of MK-7684A in Combination With Etoposide and Platinum Followed by MK-7684A vs Atezolizumab in Combination With Etoposide and Platinum Followed by Atezolizumab for the First-Line Treatment of Participants With Extensive-Stage Small Cell Lung Cancer (KEYVIBE-008)
INTERVENTIONAL
Inicio: 24 de mar de 2022
ID: NCT05224141
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral BIBF 1120 Plus Standard Pemetrexed Therapy Compared to Placebo Plus Standard Pemetrexed Therapy in Patients With Stage IIIB/IV or Recurrent Non Small Cell Lung Cancer After Failure of First Line Chemotherapy
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00806819
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone in Participants Diagnosed With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 28 de nov de 2017
ID: NCT03345407
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00795639
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Placebo-Controlled, Double-Blind, Multi-Centre, 4-week, 3-way Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF) Delivered by MDI HFO Compared With BGF Delivered by MDI HFA in Participants With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 11 de ene de 2024
ID: NCT06075095
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study of Pembrolizumab in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants With Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 28 de jun de 2019
ID: NCT03976323
Completado
Fase 3
ClinicalTrials.gov
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01316913
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multicenter, Randomized Study of Oral LDK378 Versus Standard Chemotherapy in Previously Untreated Adult Patients With ALK Rearranged (ALK-positive), Stage IIIB or IV, Non-squamous Non-small Cell Lung Cancer
INTERVENTIONAL
Inicio: 9 de jul de 2013
ID: NCT01828099
Completado
Fase 3
ClinicalTrials.gov
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
INTERVENTIONAL
Inicio: 31 de ago de 2013
ID: NCT01875003
Reclutando
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR IN ADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELY IMMUNOCOMPROMISED
INTERVENTIONAL
Inicio: 14 de jul de 2025
ID: NCT07013474
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 4 de abr de 2024
ID: NCT06317285
Completado
Fase 4
ClinicalTrials.gov
A Randomised, Multi-centre, Open Label, Cross-over Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of Neumoterol 400 and Symbicort Forte in Adults With Asthma
INTERVENTIONAL
Inicio: 14 de nov de 2014
ID: NCT02233803
Anterior
1
...
37
38
39
...
434
Siguiente
Filtros